DB02 (Anastrozole 1 mg)

Pill imprint DB02 has been identified as Anastrozole 1 mg.

Anastrozole is used in the treatment of breast cancer; breast cancer, metastatic; pubertal gynecomastia; mccune-albright syndrome; endometrial cancer and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Anastrozole 1 mg is not a controlled substance under the Controlled Substance Act (CSA).

Anastrozole

Imprint:

DB02

Strength:

1 mg

Color:

White

Shape:

Round

Availability:

Prescription only

Drug Class:

Aromatase inhibitors
Hormones/antineoplastics

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Manufacturer:

APP Pharmaceuticals, LLC

National Drug Code (NDC):

63323-0129

Inactive Ingredients:

lactose monohydrate
magnesium stearate
hypromelloses
polyethylene glycol
povidone
sodium starch glycolate type A potato
titanium dioxide

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.